🔎 Trials Near Me

ホーム › 膠腫 › カリフォルニア州

カリフォルニア州における膠腫の臨床試験

カリフォルニア州内の拠点で、膠腫に関する25件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト(英語)

MCT for the Harvard/UCSF ROBIN Center

  • University of California, San Francisco, San Francisco
被験者募集中
全年齢 · 全性別 · 2026/10/01更新 · NCT06000787

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • Children's Hospital Los Angeles, Los Angeles
  • 他7件
被験者募集中第1/2相
12 Months – 21 Years · 全性別 · 2026/10/01更新 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • UCSD Moores Cancer Center, La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
  • Stanford University, Palo Alto
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital Los Angeles, Los Angeles
  • University of California at Los Angeles, Los Angeles
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

  • Cedars-Sinai Medical Center, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT04977375

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

  • Children's Hospital Orange County (CHOC), Orange
被験者募集中第1相
5歳〜18歳 · 全性別 · 2026/09/15更新 · NCT06357377

Assessing Brain Metabolism Using MRS With Deuterated Glucose

  • University of California, San Francisco, San Francisco
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/02更新 · NCT06594315

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • University of California San Diego, La Jolla
  • University of California, Los Angeles, Los Angeles
  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • Children's Hospital Los Angeles, Los Angeles
  • University of California, San Diego Rady Children's Hospital, San Diego
  • University of California, San Francisco, San Francisco
被験者募集中第1相
1歳〜25歳 · 全性別 · 2026/08/18更新 · NCT04485559

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Los Angeles
  • Research Site, San Francisco
被験者募集中第1/2相
18歳〜130歳 · 全性別 · 2026/08/12更新 · NCT05417594

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

  • University of California Irvine, Orange
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05916313

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

  • UCI Irvine Health, Orange
被験者募集中第4相
18歳以上 · 全性別 · 2026/08/11更新 · NCT07486713

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07628634

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
  • University of California Los Angeles Rheumatology, Westwood, Los Angeles
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797

Imaging of Solid Tumors Using 18F-TRX

  • University of California, San Francisco, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06942104

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • Stanford University School of Medicine, Palo Alto
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT03510208

Hyperpolarized Imaging in Diagnosing Participants With Glioma

  • University of California, San Francisco, San Francisco
被験者募集中第1相
19歳以上 · 全性別 · 2026/06/18更新 · NCT03739411

Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

  • Moores Cancer Center, San Diego
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/06/10更新 · NCT05576103

Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

  • University of California, San Francisco, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/29更新 · NCT04540107

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
  • UCLA Hematology/Oncology, Westwood, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/20更新 · NCT06326411

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • University of California, Irvine, Irvine
  • University of California Los Angeles, Los Angeles
  • University of California at San Francisco, San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

  • Children's Health Orange County (CHOC), Orange
被験者募集中第1相
12 Months – 18 Years · 全性別 · 2026/03/17更新 · NCT04943848

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

  • University of Southern California, Los Angeles
  • University of California, San Diego, San Diego
  • University of California, San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/11更新 · NCT06504381

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/05更新 · NCT06650163

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

  • University of California, San Francisco (UCSF), San Francisco
被験者募集中観察研究
18歳〜90歳 · 全性別 · 2024/02/22更新 · NCT06118723

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。